Fortis Healthcare Considers Supreme Court Appeal in Daiichi Sankyo Dispute
Fortis Healthcare is evaluating a Delhi HC ruling on Daiichi Sankyo arbitration, potentially seeking relief from the Supreme Court.
Fortis Healthcare is contemplating a legal challenge in the Supreme Court following a recent ruling by the Delhi High Court related to the Daiichi Sankyo arbitration case. The high court's decision imposes a significant contingent liability on Fortis, mandating a forensic audit of its past transactions, which could lead to direct compensation to Daiichi Sankyo.
High Court's Forensic Audit Directive
On Monday, Justice Subramonium Prasad of the Delhi High Court issued a 213-page judgment ordering an extensive forensic audit of Fortis Healthcare's transactions. This audit spans the period when the Singh brothers controlled the company to the time IHH Healthcare Berhad took over. The court's directive seeks to identify any violations of judicial orders and assess the legality of Fortis's financial dealings during this transitional phase.
The judgment explicitly states that the court can reverse transactions and impose legal consequences on any entity found to have circumvented court orders. This includes scrutinizing the acquisition of controlling interest by IHH and the involvement of financial institutions aware of existing judicial restrictions.
Potential Supreme Court Appeal
In light of the high court's ruling, Fortis Healthcare is reviewing its options, with sources indicating a possible appeal to the Supreme Court. The company's current management cannot claim ignorance of the previous administration's actions, as highlighted in the judgment. The ruling underscores the court's authority to impose remedies, including financial compensation, on parties found to have violated court mandates.
Legal representatives for Daiichi Sankyo, including senior advocate Arvind Nigam and advocate Giriraj Subramanium, emphasized the court's capacity to enforce its orders effectively, potentially leading to significant financial implications for Fortis Healthcare.
Background of the Case
The legal battle between Fortis Healthcare and Daiichi Sankyo stems from a protracted arbitration case involving the former owners, the Singh brothers. Daiichi Sankyo has sought enforcement of an arbitration award, claiming damages due to alleged fraudulent misrepresentation during its acquisition of Ranbaxy Laboratories.
As Fortis Healthcare evaluates its next steps, the outcome of this legal confrontation could have far-reaching implications for its financial stability and corporate governance. The company's decision to approach the Supreme Court will likely hinge on the findings of the mandated forensic audit and its potential legal repercussions.